CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ('Plus” or the 'Company”), announced today that it has signed a national agreement with Elevance Health, ...

A battery liquid helps key reactions occur more easily, improving performance and bringing fluoride-based batteries closer to ...

A charity has had to employ additional chaplains to help residents cope with the trauma of homelessness in Dublin ...

Genome editing lets scientists rewrite DNA, the instruction manual inside every living cell, with a precision that was unthinkable a generation ago. Technologies such as CRISPR have made this almost ...

A slew of start-ups and academic labs are leaning on AI agents and bots, rather than humans, to speed up their chemistry ...

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers ...

ALZpath Inc., the leader in blood test-based diagnostic solutions for Alzheimer's disease, today announced a licensing agreement with Abbott (NYSE: ABT), a global healthcare leader, to incorporate ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Eisai Co., Ltd. announced today the company will present the latest findings from its Alzheimer's disease (AD) research, including lecanemab (brand name: LEQEMBI®), our anti-amyloid beta (A?) ...

New research, The Ex Files from Solidus Labs suggests that traditional execution benchmarks can mask significant cost ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The Biognosys Group, a leader in mass spectrometry-based multiomics, announces advancements across its integrated multiomics ...